115 related articles for article (PubMed ID: 10500795)
1. Evidence for the involvement of the glutathione pathway in drug resistance in AML.
Sargent JM; Williamson C; Hall AG; Elgie AW; Taylor CG
Adv Exp Med Biol; 1999; 457():205-9. PubMed ID: 10500795
[TBL] [Abstract][Full Text] [Related]
2. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
3. Detoxification of 1-chloro-2,4-dinitrobenzene in MCF7 breast cancer cells expressing glutathione S-transferase P1-1 and/or multidrug resistance protein 1.
Diah SK; Smitherman PK; Townsend AJ; Morrow CS
Toxicol Appl Pharmacol; 1999 Jun; 157(2):85-93. PubMed ID: 10366541
[TBL] [Abstract][Full Text] [Related]
4. Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse.
Massaad-Massade L; Ribrag V; Marie JP; Faussat AM; Bayle C; Dreyfus F; Gouyette A
Anticancer Res; 1997; 17(6D):4647-51. PubMed ID: 9494583
[TBL] [Abstract][Full Text] [Related]
5. Aphidicolin markedly increases the in vitro sensitivity to ara-C of blast cells from patients with AML.
Sargent JM; Elgie AW; Williamson CJ; Taylor CG
Adv Exp Med Biol; 1999; 457():567-70. PubMed ID: 10500835
[TBL] [Abstract][Full Text] [Related]
6. Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Flens MJ; Scheper RJ; Braakhuis BJ
Br J Cancer; 1998 Feb; 77(4):556-61. PubMed ID: 9484811
[TBL] [Abstract][Full Text] [Related]
7. Glutathione in childhood acute leukaemias.
Kearns P; Pieters R; Rottier MM; Veerman AJ; Schmiegalow K; Pearson AD; Hall AG
Adv Exp Med Biol; 1999; 457():211-6. PubMed ID: 10500796
[TBL] [Abstract][Full Text] [Related]
8. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
Kim HS; Min YD; Choi CH
Biochem Biophys Res Commun; 2001 Apr; 283(1):64-71. PubMed ID: 11322768
[TBL] [Abstract][Full Text] [Related]
9. The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance.
O'Brien M; Kruh GD; Tew KD
J Pharmacol Exp Ther; 2000 Aug; 294(2):480-7. PubMed ID: 10900222
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines.
Wang K; Ramji S; Bhathena A; Lee C; Riddick DS
Xenobiotica; 1999 Feb; 29(2):155-70. PubMed ID: 10199592
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione.
Lorico A; Rappa G; Finch RA; Yang D; Flavell RA; Sartorelli AC
Cancer Res; 1997 Dec; 57(23):5238-42. PubMed ID: 9393741
[TBL] [Abstract][Full Text] [Related]
12. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
Ascione A; Cianfriglia M; Dupuis ML; Mallano A; Sau A; Pellizzari Tregno F; Pezzola S; Caccuri AM
Cancer Chemother Pharmacol; 2009 Jul; 64(2):419-24. PubMed ID: 19288261
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100.
Kim HS; Lee TB; Choi CH
Biochem Biophys Res Commun; 2001 Feb; 281(1):109-14. PubMed ID: 11178967
[TBL] [Abstract][Full Text] [Related]
14. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
[TBL] [Abstract][Full Text] [Related]
15. Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells.
Morrow CS; Smitherman PK; Diah SK; Schneider E; Townsend AJ
J Biol Chem; 1998 Aug; 273(32):20114-20. PubMed ID: 9685354
[TBL] [Abstract][Full Text] [Related]
16. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
[TBL] [Abstract][Full Text] [Related]
17. [A study of the GSH contents, GST activity and the expression of GST isoenzyme and MRP in drug-resistant leukemic cell lines].
Xia R; Lin G; Li Y
Zhonghua Xue Ye Xue Za Zhi; 1998 May; 19(5):247-9. PubMed ID: 11243122
[TBL] [Abstract][Full Text] [Related]
18. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
Harbottle A; Daly AK; Atherton K; Campbell FC
Int J Cancer; 2001 Jun; 92(6):777-83. PubMed ID: 11351295
[TBL] [Abstract][Full Text] [Related]
19. Absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia.
Köhler T; Leiblein S; Borchert S; Eller J; Rost AK; Lassner D; Krahl R; Helbig W; Wagner O; Remke H
Adv Exp Med Biol; 1999; 457():177-85. PubMed ID: 10500792
[TBL] [Abstract][Full Text] [Related]
20. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
Pallis M; Turzanski J; Langabeer S; Russell NH
Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
